PA8589001A1 - Administracion dermica de un inhibidor de ciclooxigenasa-2 selectivo soluble en agua - Google Patents

Administracion dermica de un inhibidor de ciclooxigenasa-2 selectivo soluble en agua

Info

Publication number
PA8589001A1
PA8589001A1 PA20038589001A PA8589001A PA8589001A1 PA 8589001 A1 PA8589001 A1 PA 8589001A1 PA 20038589001 A PA20038589001 A PA 20038589001A PA 8589001 A PA8589001 A PA 8589001A PA 8589001 A1 PA8589001 A1 PA 8589001A1
Authority
PA
Panama
Prior art keywords
composition
subject
active agent
cox
administration
Prior art date
Application number
PA20038589001A
Other languages
English (en)
Inventor
Gary D Ewing
Guang Wei Lu
Brenda M Stoller
Kathryn M Kienle
Original Assignee
Pharmacia Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharmacia Corp filed Critical Pharmacia Corp
Publication of PA8589001A1 publication Critical patent/PA8589001A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/42—Oxazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
    • A61K9/7061—Polyacrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7069—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained otherwise than by reactions only involving carbon to carbon unsaturated bonds, e.g. polysiloxane, polyesters, polyurethane, polyethylene oxide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

UNA COMPOSICION FARMACEUTICA PARA APLICACION A UN AREA DE PIEL DE UN SUJETO PARA EL TRATAMIENTO LOCAL Y/O SISTEMICO DE UN TRASTORNO MEDIADO POR COX-2, QUE COMPRENDE UNA LAMINA DE SOPORTE QUE PUEDE CONFORMARSE DE FORMA FLEXIBLE AL AREA DE PIEL, TENIENDO LA LAMINA DE SOPORTE SUPERFICIES ENFRENTADAS QUE ESTAN RESPECTIVAMENTE DISTAL Y PROXIMAL A LA PIEL CUANDO SE APLICA; Y UN RECUBRIMIENTO SOBRE LA SUPERFICIE PROXIMAL DE LA LAMINA DE SOPORTE, QUE COMPRNDE (a) UN ADHESIVO Y (B) UN AGENTE ACTIVO SOLUBLE EN AGUA SELECCIONADO DE FARMACOS O PROFARMACOS O SUS SALES INHIBIDORES DE COX-2 SELECTIVOS, ESTANDO EL AGENTE ACTIVO EN UNA CANTIDAD TOTAL TERAPEUTICAMENTE EFECTIVA Y DISPERSO EN UNA MATRIZ QUE COMPRENDE DE CERO A MENOS DE UNA CANTIDAD EFECTIVA PARA SOLUBILIZAR EL AGENTE ACTIVO EN TOTAL DE UNO O MAS DISOLVENTES DISTINTOS DEL ADHESIVO. UN PROCEDIMIENTO DE TRATAMIENTO LOCAL DE UN SITIO DE DOLOR Y/O INFLAMACION QUE COMPRENDE APLICAR LA COMPOSICION A UNA SUPERFICIE DE PIEL DEL SUJETO, PREFERIBLEMENTE EN UNA LOCALIZACION POR ENCIMA O ADYACENTE AL SITIO DE DOLOR Y/O INFLAMACION, Y DEJAR LA COMPOSICION COLOCADA DURANTE UN PERIODO DE TIEMPO EFECTIVO PARA PERMITIR LA ADMINISTRACION DE UNA CANTIDAD LOCALMENTE TERAPEUTICA DEL AGENTE ACTIVO. UN PROCEDIMIENTO DE TRATAMIENTO SISTEMICO DE UN SUJETO QUE TIENE UN TRASTORNO MEDIADO POR COX-2, QUE COMPRENDE APLICAR LA COMPOSICION A UNA SUPERFICIE DE PIEL DEL SUJETO, Y DEJAR LA COMPOSICION COLOCADA DURANTE UN PERIODO DE TIEMPO EFECTIVO PARA PERMITIR LA ADMINISTRACION TRANSDERMICA DE UNA CANTIDAD TERAPEUTICA DEL AGENTE ACTIVO.
PA20038589001A 2002-11-21 2003-11-19 Administracion dermica de un inhibidor de ciclooxigenasa-2 selectivo soluble en agua PA8589001A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US42820102P 2002-11-21 2002-11-21

Publications (1)

Publication Number Publication Date
PA8589001A1 true PA8589001A1 (es) 2005-02-04

Family

ID=32393362

Family Applications (1)

Application Number Title Priority Date Filing Date
PA20038589001A PA8589001A1 (es) 2002-11-21 2003-11-19 Administracion dermica de un inhibidor de ciclooxigenasa-2 selectivo soluble en agua

Country Status (15)

Country Link
US (1) US20040126415A1 (es)
EP (1) EP1572166A1 (es)
JP (1) JP2006509759A (es)
AR (1) AR042102A1 (es)
AU (1) AU2003291386A1 (es)
BR (1) BR0316463A (es)
CA (1) CA2506628A1 (es)
GT (1) GT200300249A (es)
MX (1) MXPA05004989A (es)
NL (1) NL1024830C2 (es)
PA (1) PA8589001A1 (es)
PE (1) PE20041026A1 (es)
TW (1) TW200503787A (es)
UY (1) UY28086A1 (es)
WO (1) WO2004047814A1 (es)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7943166B2 (en) 2003-04-10 2011-05-17 Neurogesx, Inc. Methods and compositions for administration of TRPV1 agonists
US7666914B2 (en) * 2004-06-03 2010-02-23 Richlin David M Topical preparation and method for transdermal delivery and localization of therapeutic agents
KR20070121666A (ko) * 2005-02-14 2007-12-27 노이로제스엑스, 인코포레이티드 Ｔｒｐｖ１ 작용제의 전달용 장치
EP1865933B1 (en) * 2005-03-30 2015-11-04 Vanderbilt Royalty Sub L.P. Low-concentration capsaicin patch and methods for treating neuropathic pain
DE102005050431A1 (de) * 2005-10-21 2007-04-26 Lts Lohmann Therapie-Systeme Ag Transdermales therapeutisches System zur Verabreicherung lipophiler und/oder wenig hautpermeabler Wirkstoffe
WO2007133514A2 (en) * 2006-05-10 2007-11-22 Ceramoptec Industries, Inc. Photosensitizer formulations for topical applications
DE102006054732B4 (de) * 2006-11-21 2010-12-30 Lts Lohmann Therapie-Systeme Ag Transdermales therapeutisches System mit Ionenpaar-Mikroreservoiren
JP4327841B2 (ja) * 2006-12-20 2009-09-09 日東電工株式会社 経皮吸収製剤の製造装置および製造方法
US20090291140A1 (en) * 2008-05-21 2009-11-26 Andrew Korey Treatment of dysmenorrhea via transdermal administration of nonsteroidal anti-inflammatory drugs
JP2012020991A (ja) * 2010-06-16 2012-02-02 Takasago Internatl Corp 経皮吸収促進剤、及びこれを含有する皮膚外用製剤
US9814911B2 (en) * 2011-07-15 2017-11-14 Robert Benson Aylor Skin and hair treatments
CA2966843A1 (en) * 2014-11-10 2016-05-19 Achelios Therapeutics, Inc. Sprayable analgesic compositions
KR102042456B1 (ko) * 2018-03-22 2019-11-08 크리스탈지노믹스(주) 경피흡수제제

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0892791B1 (en) * 1996-04-12 2003-03-05 G.D. Searle & Co. N-[[4-(5-METHYL-3-PHENYLISOXAZOL-4-YL]PHENYL]SULFONYLPROPYLAMIDE and its SODIUMSALT AS PRODRUGS OF COX-2 INHIBITORS
CN1231592A (zh) * 1996-10-30 1999-10-13 瑟垃技术有限公司 作为渗透促进剂的羟乙酸及其盐的脂肪酸酯
CA2366852A1 (en) * 1999-03-01 2000-09-08 Alejandro Fabio Scasso Transdermal device comprising non-steroidal anti-inflammatory drugs incorporated in acrylic adhesive polymer matrix
US6309663B1 (en) * 1999-08-17 2001-10-30 Lipocine Inc. Triglyceride-free compositions and methods for enhanced absorption of hydrophilic therapeutic agents
IN191512B (es) * 2000-01-21 2003-12-06 Panacea Biotech
DE10032132A1 (de) * 2000-07-01 2002-01-17 Lohmann Therapie Syst Lts Dermales Therapeutisches System enthaltend nichtsteroidale Antiphlogistika mit selektiver COX-2-Hemmung
AU2002306868A1 (en) * 2001-03-28 2002-10-15 Pharmacia Corporation Therapeutic combinations for cardiovascular and inflammatory indications
CA2448627A1 (en) * 2001-05-31 2002-12-05 Pharmacia Corporation Skin-permeable composition comprising a selective cyclooxygenase-2 inhibitor a monohydric alcohol
JP4283507B2 (ja) * 2002-08-02 2009-06-24 久光製薬株式会社 経皮投与用貼付剤

Also Published As

Publication number Publication date
NL1024830C2 (nl) 2006-03-06
JP2006509759A (ja) 2006-03-23
WO2004047814A1 (en) 2004-06-10
NL1024830A1 (nl) 2004-05-26
PE20041026A1 (es) 2005-02-05
AR042102A1 (es) 2005-06-08
UY28086A1 (es) 2004-06-30
AU2003291386A1 (en) 2004-06-18
TW200503787A (en) 2005-02-01
GT200300249A (es) 2004-07-12
EP1572166A1 (en) 2005-09-14
BR0316463A (pt) 2005-10-11
US20040126415A1 (en) 2004-07-01
CA2506628A1 (en) 2004-06-10
MXPA05004989A (es) 2005-08-02

Similar Documents

Publication Publication Date Title
PA8589001A1 (es) Administracion dermica de un inhibidor de ciclooxigenasa-2 selectivo soluble en agua
NO20026171L (no) Topiske farmasöytiske formuleringer og fremgangsmåter for behandling
ES2581574T3 (es) Sistema terapéutico transdérmico para la administración del principio activo buprenorfina
PA8589101A1 (es) Lamina revestida de adhesivo para administracion dermica de un inhibidor selectivo de ciclooxigenasa-2
HUP0401281A2 (hu) Gyógyszerek kontrollált beadására alkalmas mukoadhezív, erodálható, hatóanyag-bejuttató eszköz
ATE434458T1 (de) Austragungsvorrichtungen für eine lokal begrenzte austragung eines pleurodesewirkstoffes
BRPI0415466A (pt) método e sistema de pré-tratamento para intensificar a distribuição transdérmica de fármacos
ES2188907T3 (es) Dispositivo de soporte farmaceutico adecuado ppara la administracion de compuestos farmaceuticos a las superficies de las mucosas.
TW200502017A (en) Active agent delivery device having composite members
WO2007035316A3 (en) Fallopian tube occlusion devices and methods
DK0789589T3 (da) Sammensætning, anordning og fremgangsmåde til elektrotransport-middeltilförsel
WO2009120484A3 (en) Pharmaceutical gels and methods for delivering therapeutic agents to a site beneath the skin
BRPI0417437A (pt) dispositivo para inibição da absorção, dispositivo para remoção de agente fisiologicamente ativo e dispositivo para redução do efeito de overdose
BRPI0415986A (pt) método e aparelho para reduzir a incidência do uso de tabaco
MX2012002727A (es) Sistema terapeutico transdermico para administrar fentanilo o un analogo del mismo.
WO2011139595A3 (en) Elongated biodegradable depot for sustained drug release to treat chronic pelvic pain
BR0316436A (pt) Emplastro inibidor seletivo de ciclooxigenase-2
ES2188995T3 (es) Uso de un inhibidor de la h+, k+-atpasa en el tratamiento de los polipos nasales.
HUP0204448A2 (en) Trnasdermal therapeutic system for the delivery of lerisetron
DOP2003000758A (es) Administracion dermica de un inhibidor de ciclooxigenasa-2 selectivo soluble en agua
AR046146A1 (es) Formulaciones farmaceuticas transdermicas para pulverizacion que comprenden un agente activo, un copolimero de vp/va y un vehiculo no acuoso
AR054225A1 (es) Aparato y metodo para suministro transdermico de agentes basados en epoyetina
DOP2003000759A (es) Lamina revestida de adhesivo para administracion dermica de un inhibidor selectivo de ciclooxigenasa-2
HUP0003347A2 (hu) Transzdermális terápiás rendszer (TTS) hatóanyag leadásához és eljárás a bőrre történő alkalmazáshoz
BR112022011532A2 (pt) Métodos e dispositivos para aplicação de agente terapêutico líquido em tumor sólido